| 000 | 02488 a2200625 4500 | ||
|---|---|---|---|
| 005 | 20250516100113.0 | ||
| 264 | 0 | _c20130206 | |
| 008 | 201302s 0 0 eng d | ||
| 022 | _a1878-3627 | ||
| 024 | 7 |
_a10.3233/RNN-2012-110209 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSakakima, Harutoshi | |
| 245 | 0 | 0 |
_aStimulation of functional recovery via the mechanisms of neurorepair by S-nitrosoglutathione and motor exercise in a rat model of transient cerebral ischemia and reperfusion. _h[electronic resource] |
| 260 |
_bRestorative neurology and neuroscience _c2012 |
||
| 300 |
_a383-96 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBrain Infarction _xetiology |
| 650 | 0 | 4 |
_aBrain-Derived Neurotrophic Factor _xmetabolism |
| 650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
| 650 | 0 | 4 |
_aChromones _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aExercise Therapy _xmethods |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 |
_aGlial Fibrillary Acidic Protein _xmetabolism |
| 650 | 0 | 4 | _aIn Situ Nick-End Labeling |
| 650 | 0 | 4 |
_aInfarction, Middle Cerebral Artery _xcomplications |
| 650 | 0 | 4 |
_aLocomotion _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMorpholines _xadministration & dosage |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aOncogene Protein v-akt _xmetabolism |
| 650 | 0 | 4 |
_aPhosphopyruvate Hydratase _xmetabolism |
| 650 | 0 | 4 |
_aPlatelet Endothelial Cell Adhesion Molecule-1 _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptor, trkB _xmetabolism |
| 650 | 0 | 4 |
_aRecovery of Function _xdrug effects |
| 650 | 0 | 4 | _aReperfusion |
| 650 | 0 | 4 |
_aS-Nitrosoglutathione _xtherapeutic use |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aKhan, Mushfiquddin | |
| 700 | 1 | _aDhammu, Tajinder S | |
| 700 | 1 | _aShunmugavel, Anandakumar | |
| 700 | 1 | _aYoshida, Yoshihiro | |
| 700 | 1 | _aSingh, Inderjit | |
| 700 | 1 | _aSingh, Avtar K | |
| 773 | 0 |
_tRestorative neurology and neuroscience _gvol. 30 _gno. 5 _gp. 383-96 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3233/RNN-2012-110209 _zAvailable from publisher's website |
| 999 |
_c21881537 _d21881537 |
||